Functional analyses reveal that depletion of LAPTM4B sensitizes NSCLC cells to EGFR-TKIs and attenuates downstream phospho-EGFR signaling, highlighting its essential role in sustaining oncogenic signaling under targeted therapeutic pressure. Here, LAPTM4B is linked to non-small cell lung carcinoma.